Safety and efficacy of tenecteplase versus alteplase in patients with acute ischaemic stroke (TRACE): a multicentre, randomised, open label, blinded-endpoint (PROBE) controlled phase II study

Safety and efficacy of tenecteplase versus alteplase in patients with acute ischaemic stroke (TRACE): a multicentre, randomised, open label, blinded-endpoint (PROBE) controlled phase II study

Bibliographic Details
Main Authors:	Huisheng Chen, Dong Wang, Wanliang Du, Huaguang Zheng, Ziran Wang, Zhigang Liang
Format:	Article
Language:	English
Published:	BMJ Publishing Group
Series:	Stroke and Vascular Neurology
Online Access:	https://svn.bmj.com/content/early/2021/08/23/svn-2021-000978.full

Similar Items

Is tenecteplase ready to replace alteplase to treat acute ischaemic stroke? The knowns and unknowns
by: Yi Dong, et al.

Tenecteplase versus alteplase for acute ischaemic stroke: a meta-analysis of phase III randomised trials
by: Yongjun Wang, et al.

Intravenous tenecteplase compared with alteplase for minor ischaemic stroke: a secondary analysis of the AcT randomised clinical trial
by: Dar Dowlatshahi, et al.

Replacing Alteplase with Tenecteplase: Is the Time Ripe?
by: Nishita Singh, et al.
Published: (2023-01-01)

Switching from Alteplase to Tenecteplase: Time to AcT?
by: Eric D. Goldstein, et al.
Published: (2022-09-01)

Reteplase versus alteplase for acute ischaemic stroke within 4.5 hours (RAISE): rationale and design of a multicentre, prospective, randomised, open-label, blinded-endpoint, controlled phase 3 non-inferiority trial
by: Yongjun Wang, et al.

Alteplase or tenecteplase for thrombolysis in ischemic stroke: An illustrated review
by: Annie Zhu, et al.
Published: (2022-08-01)

CLINICAL RESULTS OF THROMBOLYTIC THERAPY WITH ALTEPLASE AND TENECTEPLASE IN PATIENTS WITH MYOCARDIAL INFARCTION
by: L. A. Bondarenko, et al.
Published: (2015-12-01)

Abstract 069: Alteplase Or Tenecteplase Prior To Endovascular Therapy – Does It Matter?
by: Sheetal Hegde, et al.
Published: (2023-11-01)

CLINICAL RESULTS OF THROMBOLYTIC THERAPY WITH ALTEPLASE AND TENECTEPLASE IN PATIENTS WITH MYOCARDIAL INFARCTION
by: L. A. Bondarenko, et al.
Published: (2015-12-01)

Is tenecteplase a viable alternative to alteplase in the treatment of acute ischemic stroke?
by: Anand Girish Vaishnav
Published: (2022-01-01)

Tenecteplase Reperfusion therapy in Acute ischaemic Cerebrovascular Events-II (TRACE II): rationale and design
by: Bruce C V Campbell, et al.

Recanalization before Thrombectomy in Tenecteplase vs. Alteplase-Treated Drip-and-Ship Patients
by: Pierre Seners, et al.
Published: (2019-01-01)

Rationale and design of Tenecteplase Reperfusion Therapy in Acute Ischaemic Cerebrovascular Events III (TRACE III): a randomised, phase III, open-label, controlled trial
by: Bruce C V Campbell, et al.

Feasibility of switching from alteplase to tenecteplase for stroke thrombolysis – A retrospective cohort analysis
by: Vilhelm Sjögren, et al.
Published: (2023-06-01)

Biosimilar tenecteplase versus alteplase in acute ischemic stroke: A real world study
by: Ayush Mohan, et al.
Published: (2023-01-01)

Tenecteplase versus alteplase for the treatment of acute ischemic stroke: a meta-analysis of randomized controlled trials
by: Jian Huang, et al.
Published: (2024-12-01)

Tenecteplase and alteplase for thrombolysis of acute ischemic stroke within 4.5 hours: An efficacy and safety study
by: Nikita Dhar, et al.
Published: (2022-01-01)

Different doses of tenecteplase vs alteplase in thrombolysis therapy of acute ischemic stroke: evidence from randomized controlled trials
by: Xu N, et al.
Published: (2018-07-01)

Real-world data of tenecteplase vs. alteplase in the treatment of acute ischemic stroke: a single-center analysis
by: Yu Yao, et al.
Published: (2024-04-01)

Tenecteplase vs. Alteplase for Intravenous Thrombolytic Therapy of Acute Ischemic Stroke: A Systematic Review and Meta-Analysis
by: Ziyi Shen, et al.
Published: (2023-08-01)

Tenecteplase vs. alteplase for treatment of acute ischemic stroke: A systematic review and meta-analysis of randomized trials
by: Hassan Kobeissi, et al.
Published: (2023-01-01)

Real-world comparative safety and efficacy of tenecteplase alteplase in acute ischemic stroke patients with large vessel occlusion
by: Klearchos Psychogios, et al.
Published: (2021-01-01)

Tenecteplase versus alteplase in treatment of acute ST-segment elevation myocardial infarction: A randomized non-inferiority trial
by: Xingshan Zhao, et al.
Published: (2024-02-01)

Abstract 040: Hemorrhagic Conversion Patterns After Transition of Stroke Thrombolysis from Alteplase to Tenecteplase; Real‐World Experience
by: Mohamad Ezzeldin, et al.
Published: (2023-11-01)

Efficacy outcomes of tenecteplase versus alteplase in patients with ischemic stroke in therapeutic window: experience from a single institution
by: Amit Chandra, et al.
Published: (2023-01-01)

Treatment with intravenous alteplase in ischaemic stroke patients with onset time between 4.5 and 24 hours (HOPE): protocol for a randomised, controlled, multicentre study
by: Ying Zhou, et al.

Intensive blood pressure reduction with intravenous thrombolysis therapy for acute ischaemic stroke (ENCHANTED): an international, randomised, open-label, blinded-endpoint, phase 3 trial
by: Anderson, C, et al.
Published: (2019)

Effects of alteplase on survival after ischaemic stroke (IST-3): 3 year follow-up of a randomised, controlled, open-label trial
by: Berge, E, et al.
Published: (2016)

Alteplase for the treatment of acute ischaemic stroke: a single technology appraisal
by: M Lloyd Jones, et al.
Published: (2009-09-01)

Tenecteplase or Alteplase Better in Patients with Acute Ischemic Stroke Due to Large Vessel Occlusion: A Single Center Observational Study
by: Agnete Teivane, et al.
Published: (2022-08-01)

Efficacy and safety of multiple tenecteplase doses compared to alteplase for acute ischemic stroke patients, a frequentist network meta-analysis
by: A. Negida, et al.
Published: (2022-01-01)

Normal Appearing Ischaemic Brain Tissue on CT and Outcome After Intravenous Alteplase
by: Grant Mair, et al.
Published: (2022-06-01)

Efficacy and safety of glibenclamide therapy after intracerebral haemorrhage (GATE-ICH): A multicentre, prospective, randomised, controlled, open-label, blinded-endpoint, phase 2 clinical trial
by: Jingjing Zhao, et al.
Published: (2022-11-01)

Hyperdense artery sign, symptomatic infarct swelling and effect of alteplase in acute ischaemic stroke
by: Ming Liu, et al.

Statistical analysis plan for the randomized controlled trial Tenecteplase in Wake-up Ischaemic Stroke Trial (TWIST)
by: Agnethe Eltoft, et al.
Published: (2022-05-01)

Endovascular treatment with or without intravenous alteplase for acute ischaemic stroke due to basilar artery occlusion
by: Liping Liu, et al.
Published: (2022-06-01)

The efficacy and safety of tenecteplase compared with alteplase in adult patients with acute ischemic stroke: an updated systematic review and meta-analysis of ten randomized controlled trials
by: Karthikeyan Chinniah, et al.
Published: (2023-10-01)

Different doses of tenecteplase vs. alteplase for acute ischemic stroke within 4.5 hours of symptom onset: a network meta-analysis of randomized controlled trials
by: Huo Liang, et al.
Published: (2023-06-01)

Comparison of tenecteplase and streptokinase in prosthetic mitral thrombosis: Tenecteplase as an alternative to surgery
by: V. Ramkumar, et al.
Published: (2017-11-01)